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http:WHAT THIS PAPER ADDS
This study compares the results of redo carotid endarterectomy (CEA) and of carotid artery stenting (CAS) in the
management of post-CEA restenosis. Both techniques are feasible and safe; in the long-term setting, endo-
vascular surgery seems to surprisingly provide better durability than redo CEA.Aim of the study: To compare early and long term results of open and endovascular treatment of post-carotid
endarterectomy (CEA) restenosis in a single centre experience.
Methods: From January 2005 to December 2011, ninety-nine consecutive interventions for primary severe post-
CEA restenosis were performed: in 41 cases (41%, Group 1) open repair was carried out, whereas the remaining
58 patients (59%, group 2) underwent an endovascular treatment. Data concerning these interventions were
prospectively collected in a dedicated database containing main pre, intra and postoperative variables.
Early results in terms of 30-day stroke and death rates were analysed and compared with c2 test.
Follow-up results were analysed with Kaplan Meier curves and compared with log-rank test.
Results: Mean time from primary CEA was 75 months in group 1 and 42 months in group 2 (p ¼ 0.002; 95% CI
12e52). There were no differences between the two groups in terms of demographic data, comorbidities, risk
factors for atherosclerosis, preoperative clinical status or degree of stenosis on the operated side. In group 1
interventions consisted of redo-CEA in 37 patients and of carotid bypass in the remaining 4; all the patients in
group 2 underwent stent placement with cerebral protection device. No perioperative deaths and ipsilateral
neurological events occurred in both groups. One patient in group 1 suffered from a non-fatal acute myocardial
infarction. Other six patients (14.5%) experienced transient cranial nerve injuries, with complete regression at 1-
month follow-up; two patients had postoperative dysphagia due to neck haematoma, which was medically
managed. Neither access-related nor systemic complications were recorded in group 2.
Follow-up was available in 98% of the patients with a median duration of 24 months (range 3e72).
There were no differences in terms of 4-year estimated survival and stroke-free survival, whereas patients in
group 1 were more likely to develop severe (>80%) secondary restenosis (28.3% and 6.5%, respectively, p¼ 0.01,
log rank 6.3) and to undergo secondary reintervention (22% and 11%, respectively p ¼ 0.01, log rank 6).
Conclusions: despite the selection limits and bias of this study, in our experience open and endovascular surgery
provided similar perioperative results in the management of post-CEA restenosis. Long term outcomes are
similar, too, despite a slight increase in secondary restenosis and recurrent reinterventions among open surgery
patients, warranting further studies and analysis.
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Redo CEA is considered a challenging procedure because
of the increased risk of cranial-nerve injuries and wound
complications,3 and thus, the use of carotid artery stenting
(CAS) has been the treatment of choice in such patients in
recent years.4 However, there are few studies in the liter-
ature that directly compare the early and long-term results
of the two procedures in post-CEA stenosis.
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early and long-term results of open and endovascular
treatments of post-CEA stenosis in a single centre.MATERIALS AND METHODS
From January 2005 to December 2011, 2341 consecutive
open and endovascular interventions for extracranial carotid
artery disease were performed at our academic institution.
Data concerning these interventions were prospectively
collected in a dedicated database whose characteristics
have been previously described.5 A post hoc analysis of this
database was performed, and 99 interventions for post-CEA
restenosis were found; the interventions were performed
with an open repair (OR) in 41 cases (group 1) and with CAS
in the remaining 58 cases (group 2).
The two groups of patients were compared for demo-
graphic data, common risk factors for atherosclerosis and
co-morbidities. Risk factors and co-morbidities included
arterial hypertension (deﬁned as blood pressure >140/
85 mmHg or the need for antihypertensive drugs), hyper-
lipaemia (deﬁned as both triglycerides and cholesterol
values >200 mg dl1), coronary artery disease (history of
myocardial infarction, angina and previous coronary revas-
cularisation), diabetes mellitus (deﬁned as the need for
speciﬁc drugs to maintain metabolic control) and peripheral
arterial disease (an ankle/brachial index <0.9). Patients
were considered to be asymptomatic in the absence of
neurological symptoms (transient ischaemic attack (TIA) or
stroke) within 6 months from the intervention.
All of the patients underwent both duplex scanning of
the extracranial vessels and angio-computed tomography
(CT) scans of the intra- and extracranial vessels and the
cerebral parenchyma. The degree of carotid stenosis was
measured using the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) criteria. The velocity criteria
for the duplex deﬁnition of the severity of stenosis were
those indicated in our national guidelines.6 The indication
for treatment was the presence of symptomatic stenosis
>50% or asymptomatic stenosis >80%. We did not decline
any patient who came to our attention with such charac-
teristics during the study period.
During the preoperative workup, a phoniatrist conducted
an otolaryngological evaluation of the motility of the vocal
cords and the damage to the cranial nerves. The selection of
either open or endovascular treatment was not rando-
mised; it was made at the surgeon’s discretion on the basis
of several considerations. Patients undergoing CAS were
considered to be too high risk for OR because of the
characteristics of the neck and the previous surgical wound,
the site of the lesion (distal lesions beyond the angle of the
jaw), the presence of past cranial nerve injuries and the
duplex appearance of the lesion. Speciﬁcally, patients with
inhomogeneous hypoechoic and irregular lesions were
selected for redo CEA, while patients with uniform, homo-
geneous and smooth lesions were preferentially selected
for CAS. However, CAS was not performed in patients
with severely angulated/tortuous carotids, a thrombuscontaining lesions on duplex and CT scan assessments and
difﬁcult aortic arches (Type III/IV arches).
Open repair
In the OR group, the selection of anaesthesia was at the
discretion of the operating surgeon and the anaesthesiol-
ogist, with consideration of the patient’s preference.
Patients undergoing OR under general anaesthesia had
cerebral monitoring with somatosensory evoked potentials
(SEPs) and selective shunt insertion on the basis of the SEP
abnormalities. With local anaesthesia or the previously
described general anaesthesia with cooperating patients,7
a carotid shunt was inserted on the basis of clinical
neurologic monitoring during carotid clamping.
Open surgical intervention was performed following our
standard protocol,8 which consists of the routine placement
of a polyurethane patch; however, in patients with exten-
sive proximal or distal lesions or with arterial walls of poor
quality, a vein or prosthetic common-to-internal carotid
bypass was performed.
When the intervention was completed, angiography was
routinely performed. Postoperative medical treatment con-
sisted of a single antiplatelet treatment. All of the patients
were treated with statin therapy for an indeﬁnite period of
time.
Carotid stenting
CAS was performed by vascular surgeons in the operating
room initially and then in the angiographic suite under local
anaesthesia, supplemented with intravenous sedation or
analgesia when required. Clinical monitoring of cerebral
functions was conducted.
In all of the cases, a percutaneous access to the common
femoral artery was used; following the placement of a long
introducer sheath and the administration of 5000 IU of
intravenous sodium heparin, the catheterisation of the
target common carotid artery was performed using the
telescopic technique. Once the sheath was placed in the
site, the lesion was crossed with a cerebral distal protection
device. In selected cases, a proximal protection device was
preferred. Post-dilatation of the stent and completion
angiography of the extra- and intracranial vessels (before
and after the removal of the distal ﬁlter, when used) was
routinely performed. Technical success was deﬁned as
residual stenosis <30% at the completion angiography. A
double antiplatelet regimen (aspirin and clopidogrel or
ticlopidine) was adopted in all of the patients for at least 6
months, after which ASA was administered indeﬁnitely. All
of the patients received long-term statin therapy.
Early and follow-up evaluation
A neurological evaluation was independently performed by
an experienced neurologist at 30 days in all of the patients to
determine the presence of minor or major strokes. A minor
stroke was deﬁned as any postoperative neurological event
of more than a 24-h duration followed by a recovery in the
subsequent weeks or months either without impairment or
Table 2. Clinical and anatomical features.
Group 1
(41 pts.)
Group 2
(58 pts.)
p
Presence of preoperative
symptoms
10 (25%) 13 (22.5%) 0.8
- TIA 6 13
- Minor stroke 3 e
- Major stroke e e
- Vertebrobasilar 1 e
Asymptomatic patients 31 (75%) 45 (77.5%)
Degree of stenosis
- 60e80% 10 (25%) 13 (22.5%) 0.8
- >80% 31 (75%) 43 (74%) 0.8
- Near-occlusion e 2 (3.5) 0.9
Contralateral occlusion 2 (5%) 2 (3.5%) 0.4
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was deﬁned as any postoperative neurological event of more
than a 24-h duration with residual impairment. An otolar-
yngological evaluation was also performed at 30 days.
Patients with cranial nerve injuries at the 30-day evaluation
were further followed up every 6 months.
The perioperative (<30 days) results of interventions
were analysed and compared for stroke, death and cranial
nerve injuries with the c2 test and Fisher’s exact test, when
necessary.
Follow-up was performed at 1, 3, 6 and 12 months and
yearly thereafter with a clinical examination and a duplex
scan. Patients who did not receive follow-up examinations
were interviewed by telephone. Points addressed during
telephone interviews included the patient’s survival or
cause of death, if known, as well as neurological events and
their time of appearance. Moreover, the patients were
asked to report the results of the last duplex ultrasound,
wherever it was performed, to assess the status of the
operated internal carotid artery. Additional data regarding
long-term survival and major cardiovascular events were
obtained from the Regional Health Care database. Follow-
up data were analysed by a life-table analysis (the Kaplane
Meier test) for survival, stroke-free survival, freedom from
secondary restenosis and freedom from secondary reinter-
ventions, and the results of the two groups were compared
by the log-rank test. Indications for secondary reinterven-
tions were the same as for primary reinterventions. Data
were reported in the maximum time frame with a standard
error (SE) <0.10. Statistical signiﬁcance was deﬁned as a p
value <0.05.
Statistical analysis was performed with dedicated
Windows software (Statistical Package for the Social
Sciences (SSPS) 18; SPSS Inc., Chicago, IL, USA).
RESULTS
Demographic data, risk factors, co-morbidities and clinical
and anatomical status
There were no differences between the two groups
regarding demographic data, co-morbidities and risk factors
for atherosclerosis (Table 1) or regarding clinical presenta-
tion at the time of operation or the degree of carotid
stenosis (Table 2). One patient in group 1 had a combinedTable 1. Patients’ demographic data, risk factors and comorbidities.
Group 1
(41 pts.)
Group 2
(58 pts.)
p
Female gender 12 (29%) 18 (31%) 0.8
Median age (years) 66 70.3 0.6
Hyperlipaemia 23 (56%) 40 (69%) 0.1
Diabetes 7 (17%) 15 (27%) 0.2
Arterial hypertension 35 (85%) 52 (89%) 0.5
Coronary artery disease 14 (34%) 13 (22.5%) 0.2
Peripheral artery disease 13 (31%) 19 (32%) 0.9
Current smoker 10 (25%) 7 (12%) 0.1
Past smoker 25 (60%) 40 (69%) 0.1coronary bypass graft and carotid intervention due to
concomitant unstable angina and asymptomatic carotid
restenosis, which is typical in our experience. We did not
record any case of a patient with previous neck irradiation
or non-vascular surgical intervention. One patient in group
2 had an extremely distal lesion, beyond the angle of the
jaw, and another patient, who had undergone bilateral CEA,
suffered from permanent, contralateral vocal-cord paralysis.
The mean time from the primary CEA was 75  42 months
in group 1 and 42  38 months in group 2 (p ¼ 0.002; 95%
conﬁdence interval (CI) 12e52); correspondingly, the
percentage of early (<24 months) carotid restenosis was
higher in group 2 (36 patients, 62%) than in group 1 (nine
patients, 22%; p < 0.001). In group 1, primary interventions
with a patch closure were performed in 33 cases (80%) and
with primary closure in the remaining 8 cases; the corre-
sponding ﬁgures in group 2 were 51 (88%; p ¼ 0.5) and 7,
respectively.
Intra-operative details
In group 1, either local or general anaesthesia with coop-
erating patients and clinical monitoring were used in 15
interventions (36.5%), while the remaining 26 patients had
general anaesthesia with SEP monitoring. The cumulative
shunt-insertion rate was 12% (ﬁve cases); in four cases,
a shunt was placed in patients undergoing general
anaesthesia.
For arterial reconstruction, a polyurethane patch closure
was used in 37 cases (90%); four patients had a common to
internal carotid bypass, in one case with an autologous
saphenous vein and in three cases with expanded poly-
tetraﬂuoroethylene (ePTFE).
In group 2, a protective ﬁlter (Epiﬁlter EZ 6.5, 0.018 in.
over a 0.014 in. guidewire, Boston Scientiﬁc, Natick, MA,
USA) was placed in the distal internal carotid artery in all
but three patients, who had proximal protection devices
(NPS system,W.L. Gore & Associates Inc, Flagstaff, AZ, USA).
In the majority of the cases (37 patients), an elgiloy stent
was inserted; in the remaining 21 cases, a nitinol stent was
used. The mean diameter of the placed stent was 7.7 mm
(range 5e10 mm); the mean length of the covered segment
of the carotid artery was 37 mm (range 30e40 mm).
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Technical success was achieved in all of the patients in
group 2.
Neither perioperative deaths nor ipsilateral and contra-
lateral neurological events occurred in either group. One
patient in group 1 developed typical chest pain with
a signiﬁcant increase of troponin I circulating levels and
electrocardiographic signs of a myocardial infarction on the
ﬁrst postoperative day. The patient underwent a coronary
angiography with a successful stent placement.
Six patients (14.5%) in group 1 suffered from post-
operative cranial nerve injuries: in three cases, an isolated
deﬁcit of hypoglossal nerve was present, in two patients,
there was a deﬁcit of a laryngeal nerve and one patient had
a concomitant deﬁcit of both nerves. In all of these cases,
an otolaryngological examination at 30 days showed
complete regression of the deﬁcit. Two additional patients
developed postoperative dysphagia and hoarseness due to
haematomas of the pyriform sinus, with a complete
recovery of symptoms after 30 days of conservative medical
management. Neither access-related nor systemic compli-
cations were recorded in group 2.Figure 1. KaplaneMeier curves for freedom from recurrent rein-
tervention with numbers of patients at risk and standard error
values at 48 months.Follow-up results
Follow-up was available in 97 patients (98% of the study
group) for a median duration of 24 months (range 3e72
months).
Six deaths were recorded during the follow-up, four in
group 1 and two in group 2. In group 1, the cause of death
was unknown in two patients, one patient died from acute
myocardial infarction and one patient died from cancer. In
group 2, one of the patients died from lung cancer, and the
other patient died from acute respiratory failure. The esti-
mated survival at 4 years was 77.3% in group 1 (SE 0.10)
and 87.8% in group 2 (SE 0.08; p ¼ 0.2, log rank 1.6).
No ipsilateral stroke occurred during the follow-up; one
patient in group 1 suffered a contralateral stroke due to an
occlusion of the internal carotid artery at 5 years. Stroke-
free survival rates at 4 years were equal to the survival
rates.
Severe (>80%) secondary restenosis occurred in seven
patients in group 1 and in three patients in group 2, and it
was asymptomatic in all but one patient in group 2, who
suffered from a TIA. Two additional patients in group 1 had
asymptomatic occlusions of the targeted internal carotid
artery. The estimated 48-month freedom from secondary
restenosis rates were 71.7% in group 1 (SE 0.08) and 93.5%
in group 2 (SE 0.04; p ¼ 0.01, log rank 6.3).
Nine of the 10 patients who developed severe secondary
restenosis underwent further reintervention, while one
patient (in group 2) refused a secondary intervention. The
reinterventions consisted of carotid stenting in six patients
in group 1, while one patient underwent an ePTFE common-
to-internal carotid bypass; in group 2, one patient had
a new percutaneous transluminal angioplasty with a cutting
balloon, and the remaining patient underwent stent
removal and polyurethane patching. No postoperativeevents occurred in the patients who underwent secondary
reinterventions.
The estimated 48-month freedom from recurrent inter-
vention rate was 78% in group 1 (SE 0.08) and 89% in group
2 (SE 0.08; p ¼ 0.01, log rank 5.9; Fig. 1).
DISCUSSION
It has been suggested that post-CEA restenosis is caused by
intimal hyperplasia in the ﬁrst 12e24 months after surgery
and later by the progression of an underlying atheroscle-
rotic disease,9 although recent studies support the
hypothesis that early and late recurrent lesions are different
aspects of the atherosclerotic evolution of intimal hyper-
plasia observed at different time points along
a continuum.10 Its incidence has been reported to range
from 1% to 36%,1 with <10% of patients developing severe
restenosis in the primary published series11 and a progres-
sively decreasing risk over time.12 The relationship between
restenosis and ipsilateral neurological events is still unclear,
even though a higher percentage of hemispheric symptoms
has been described in the presence of severe progressive
restenosis.13 While there is a general consensus regarding
the indication for treatment in symptomatic lesions, some
controversy does exist concerning the need for treating
asymptomatic lesions.3 Our policy has been to routinely
treat symptomatic >50% restenoses, whereas we have
treated only high-grade asymptomatic lesions, whose
evolution has been described to be predictive of an ipsi-
lateral stroke.14
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years to be the standard treatment for post-CEA restenosis,
with excellent long-term results10,15 with regard to the
prevention of stroke and recurrent restenosis. However, this
type of intervention does not have a negligible rate of
perioperative complications, primarily because of the need
to operate in a previously treated surgical ﬁeld. Although
the rates of perioperative stroke and death are similar to
those for primary interventions, the increased risk for
cranial-nerve injuries, whose incidence has been reported
to range between 4% and 15%, is problematic.1,3,15
Because of the increased risk of local complications and
the stable nature of intimal hyperplasia, the use of endo-
vascular surgery has been proposed and widely used in the
past two decades with promising results, particularly in
patients with early restenosis.16e18 Consequently, several
international guidelines suggest that CAS should be
considered the treatment of choice in post-CEA restenosis,
particularly in symptomatic lesions.4,19
There are, however, few studies that directly compare the
two treatment modalities, and none of them are prospective
and randomised.1,2,20e22 AbuRahma et al.1 retrospectively
compared the results of 72 open reinterventions with those
obtained in 120 CAS interventions and found no signiﬁcant
difference in the perioperative outcomes; however, a higher
incidence of >50% secondary restenosis was detected in
patients treated with CAS. Similar results were obtained by
Attigah et al.,2 who also found no difference between open
surgery and CAS in long-term outcomes.
In the present study, we retrospectively compared the
results of open reintervention and CAS in post-CEA reste-
nosis. Similar to the reports of the other cited studies, our
groups were strictly homogeneous in terms of demographics,
co-morbidities and clinical factors, although two patients in
group 2 had anatomical characteristics that made CAS the
preferred option. The primary difference between the two
groups was the type of lesions treated. Patients undergoing
open surgery had more frequent late restenosis, while the
patients in the CAS group were more frequently treated for
early restenosis. It is well known that early restenosis is
a ﬁbrous and hyperplastic stable lesion, with a low potential
for microembolisation, which is why stenting is commonly
used in such patients; on the contrary, late atherosclerotic
recurrent plaques at high embolic risk were preferentially
treated in our experience with open surgery. This difference,
which is present also in other published studies and reﬂects
the current attitude in everyday practice, represents an
important selection bias affecting our results. However, our
selection criteria derive from a deep evaluation of clinical and
anatomical characteristics and an accurate, non-invasive
assessment of carotid plaque that permits the distinction
between early and late restenosis.
The perioperative outcomes were excellent in both
groups, without differences for the ‘end’ points of peri-
operative stroke, myocardial infarction and/or death, and
this ﬁnding may derive from the above-cited selection of
patients on the basis of the lesion’s morphology and
anatomy. As expected, we recorded a signiﬁcant number oflocal complications in the open surgery group, with a rate of
cranial nerve injuries of 14%, similar to that reported in
AbuRahma’s series and slightly higher than that reported in
other surgical series; however, we did not ﬁnd any perma-
nent lesions, and all of the patients had complete recov-
eries within the ﬁrst postoperative month.
There were no differences between the two groups
regarding long-term survival and neurological outcomes;
there were no ipsilateral neurological events, thus con-
ﬁrming the effectiveness of both approaches in stroke
prevention during follow-up.
An interesting ﬁnding in our study was the signiﬁcant
difference in favour of endovascular treatment with regard
to recurrent restenosis and tertiary interventions in the
long-term setting.
This ﬁnding is somewhat uncommon in the contemporary
literature; in fact, while Attigah et al.2 did not report in their
comparative series any signiﬁcant difference in recurrences
of restenosis and in redo reinterventions, AbuRahma et al.1
showed an increased incidence of >50% in-stent restenosis
in patients who underwent CAS, with equivalent rates of
freedom from >80% restenosis at 4 years.
Only Bettendorf et al.22 reported results similar to those in
the present series, with a 14% rate of secondary recurrences
among patients treated with redo CEA compared with 6% in
patients treated with CAS, and they found that the failure to
take b-blockers during the follow-up was an independent
predictor for multiple recurrences. The explanation for this
result in our series is quite difﬁcult to surmise. We can
suppose that the difference in postoperative medical treat-
ment among the two groups may have contributed to this
ﬁnding; moreover, it is possible that differences in the types
of treated lesions inﬂuenced the rates of secondary reste-
nosis and that recurrent atherosclerotic plaques were likely
with the higher burden of following recurrent stenosis.
Finally, we could have been inﬂuenced by the early results in
the literature reporting high in-stent restenosis rates, to
adopt a stricter control of risk factors in patients treated with
CAS than in patients treated with redo CEA, thus optimising
the postoperative strategy primarily in the former patients. It
is likely that a randomised study with a strict medical treat-
ment protocol would provide more reliable data on this
issue. However, once recurrent restenosis has occurred, it
can be safely treated with both open and endovascular
surgery, as demonstrated by our experience.
Our study has several limitations: it is a retrospective study,
with a limited number of patients and events. Moreover, as
already mentioned, a selection bias in the choice of treat-
ment does exist. On the other hand, the two groups are
homogeneous from demographic and clinical points of view,
and the accuracy of the evaluations of the perioperative and
follow-up outcomes indicates the reliability of our results,
potentially adding, in our opinion, something to the hereto-
fore paucity of data in the contemporary literature.
On the basis of such results, we were further convinced
to maintain our tailored approach to patients with post-CEA
restenosis. Patients with late restenosis or with anatomi-
cally complex lesions are more likely to be better managed
442 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 5 May/2013with redo open surgery, provided that we accept the risk for
perioperative local and transient complications and for
a late tertiary intervention, which can be safely performed
in most cases with an endovascular approach. In patients
with early restenosis, CAS may be preferred, if no
anatomical contraindications exist. However, a deﬁnitive
conclusion will require a prospective study comparing the
two strategies in patients with similar lesions.
CONCLUSIONS
In our experience, both open and endovascular surgery are
safe and effective in the treatment of post-CEA restenosis,
even if in everyday practice we tend to use them for
different types of lesions. Early results are excellent in both
groups, and long-term outcomes are also similar, despite
a slight increase in secondary restenosis and recurrent
reinterventions among open-surgery patients, warranting
further studies and analysis.
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